https://www.healthday.com/healthpro-news/cancer/asco-gi-zanidatamab-chemo-beneficial-in-her2-positive-gastroesophageal-cancer
For patients with human epidermal growth factor 2-positive metastatic or locally advanced unresected gastroesophageal adenocarcinoma, zanidatamab and...
zanidatamabchemoextendssurvivalcancer